Vaccines for preventing rotavirus diarrhoea: vaccines in use
Hanna Bergman, Nicholas Henschke, Daniel Hungerford, Femi Pitan, Duduzile Ndwandwe, Nigel A. Cunliffe, Karla Soares‐Weiser
Abstract
Rotavirus is a common cause of diarrhoea, diarrhoea-related hospital admissions, and diarrhoea-related deaths worldwide. Rotavirus vaccines prequalified by the World Health Organization (WHO) include Rotarix (GlaxoSmithKline), RotaTeq (Merck), and, more recently, Rotasiil (Serum Institute of India Ltd.), and Rotavac (Bharat Biotech Ltd.).
Topics & Concepts
MedicineRotavirusCochrane LibraryConfidence intervalClinical trialRandomized controlled trialRelative riskPlaceboMEDLINEScience Citation IndexPediatricsFamily medicineCitationAlternative medicineDiarrheaInternal medicinePathologyLibrary scienceComputer sciencePolitical scienceLawViral gastroenteritis research and epidemiologyViral Infections and Immunology ResearchHepatitis Viruses Studies and Epidemiology